STX - Shield Therapeutics really starting to fire on all cylinders
(NewsDirect)
Shield Therapeutics PLC (AIM:STX,OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner from Proactiveafter the commercial-stage specialty pharmaceutical company released abusiness update containing plenty of new information about itsperformance during the second quarter.
Madison gives an overview of the update, highlighting strong USsales growth for its Accrufer/Feraccru iron deficiency treatment as aresult of the commercial expansion with Viatris that was completed inMay, which brought the combined sales team to 100 people. He stressesthat the team is "really starting to fire on all cylinders"but "hasn't really hit full stride yet...I think there'smore that we can do and we're constantly looking at how we tweakthe business and what adjustments we can make to further that growth -but [we're] off to a really nice start."
He also mentions a new marketing campaignand the addition of Andy Hurley as Chief Commercial Officer, who hedescribes as a "veteran on the commercial side... I couldn'tbe more pleased with his performance."
ContactDetails
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.